Skip to content

BRUPHARM PHARMALAB: what changed

BE 0785.641.404NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€10,043
2024 · -€45,089+€55,132
Equity
-€102,855
2024 · -€112,898+€10,043
Cash
€3,496
2024 · €77+€3,419
Balance sheet total
€298,430
2024 · €243,802+€54,628

Largest movements

2024 to 2025
Assets
  • Deferred charges and accrued income +€50,000

    first reported in 2025, at €50,000

  • Receivables within one year +€38,663

    up €38,663 (+110%), from €35,255 to €73,918

    of which Other amounts receivable: +€48,663

  • Intangible fixed assets -€37,500

    down €37,500 (-18.6%), from €201,781 to €164,281

  • Cash +€3,419

    up €3,419 (+4,437%), from €77 to €3,496

    mainly Accrued charges and deferred income (+€52,624) and Depreciation (+€37,900)

Equity and liabilities
  • Accrued charges and deferred income +€52,624

    first reported in 2025, at €52,624

  • Trade debts -€24,986

    no longer reported in 2025; in 2024 it stood at €24,986

  • Tax, wage and social debts +€19,334

    up €19,334 (+106%), from €18,321 to €37,655

    of which Taxes: +€37,655

  • Profit (loss) carried forward +€10,043

    up €10,043 (+4.7%), from -€212,898 to -€202,855

Income statement
  • Turnover +€125,346

    up €125,346 (+251%), from €49,927 to €175,274

  • Gross operating margin +€82,885

    up €82,885 (+2,669%), from €3,105 to €85,990

  • Purchases and services +€39,885

    up €39,885 (+80.5%), from €49,559 to €89,444

  • Staff costs +€38,530

    up €38,530 (+430%), from €8,965 to €47,496

  • Financial income +€11,564

    first reported in 2025, at €11,564

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€45,089
Gross operating margin +€82,885
Staff costs -€38,530
Depreciation -€51
Other operating charges -€97
Financial income +€11,564
Financial charges -€639
Result 2025 €10,043
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€4,064
Investment -€645
Financing €0
Cash 2024 €77
Net result for the year +€10,043
Depreciation +€37,900
Stocks and contracts +€200
Receivables within one year -€38,663
Deferred charges and accrued income -€50,000
Trade debts -€24,986
Tax, wage and social debts +€19,334
Other debts -€2,387
Accrued charges and deferred income +€52,624
Investment in fixed assets (net) -€645
Cash 2025 €3,496
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €243,802 €298,430 +€54,628 +22.4%
Fixed assets 21/28 €202,059 €164,805 -€37,254 -18.4%
Intangible fixed assets 21 €201,781 €164,281 -€37,500 -18.6%
Tangible fixed assets 22/27 €278 €524 +€246 +88.5%
Plant, machinery and equipment 23 €149 €0 -€149 -100%
Furniture and vehicles 24 €129 €524 +€395 +307%
Current assets 29/58 €41,744 €133,626 +€91,882 +220%
Stocks and contracts in progress 3 €6,412 €6,212 -€200 -3.1%
Stocks 30/36 €6,412 €6,212 -€200 -3.1%
Amounts receivable within one year 40/41 €35,255 €73,918 +€38,663 +110%
Trade receivables 40 €35,255 €25,255 -€10,000 -28.4%
Other amounts receivable 41 - €48,663 +€48,663
Cash at bank and in hand 54/58 €77 €3,496 +€3,419 +4,437%
Deferred charges and accrued income 490/1 - €50,000 +€50,000
Total equity and liabilities 10/49 €243,802 €298,430 +€54,628 +22.4%
Equity 10/15 -€112,898 -€102,855 +€10,043 +8.9%
Contributions 10/11 €100,000 €100,000 = 0.0%
Capital 10 €100,000 €100,000 = 0.0%
Issued capital 100 €100,000 €100,000 = 0.0%
Profit (loss) carried forward 14 -€212,898 -€202,855 +€10,043 +4.7%
Amounts payable 17/49 €356,701 €401,286 +€44,585 +12.5%
Amounts payable within one year 42/48 €356,701 €348,662 -€8,039 -2.3%
Trade debts 44 €24,986 - -€24,986
Suppliers 440/4 €24,986 - -€24,986
Taxes, remuneration and social security 45 €18,321 €37,655 +€19,334 +106%
Taxes 450/3 - €37,655 +€37,655
Remuneration and social security 454/9 €18,321 - -€18,321
Other amounts payable 47/48 €313,394 €311,007 -€2,387 -0.8%
Accrued charges and deferred income 492/3 - €52,624 +€52,624
Turnover 70 €49,927 €175,274 +€125,346 +251%
Goods, raw materials, services and sundry goods 60/61 €49,559 €89,444 +€39,885 +80.5%
Remuneration, social security and pensions 62 €8,965 €47,496 +€38,530 +430%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €37,849 €37,900 +€51 +0.1%
Other operating charges 640/8 €850 €947 +€97 +11.4%
Gross operating margin 9900 €3,105 €85,990 +€82,885 +2,669%
Operating profit (loss) 9901 -€44,559 -€352 +€44,207 +99.2%
Financial income 75/76B - €11,564 +€11,564
Recurring financial income 75 - €11,564 +€11,564
Financial charges 65/66B €530 €1,169 +€639 +121%
Recurring financial charges 65 €530 €1,169 +€639 +121%
Profit (loss) for the period before taxes 9903 -€45,089 €10,043 +€55,132
Profit (loss) for the period 9904 -€45,089 €10,043 +€55,132
Profit (loss) for the period to be appropriated 9905 -€45,089 €10,043 +€55,132

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.

Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.

Adjusted equity -€267,136

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€102,855
Intangible fixed assets (21)
-€164,281
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€267,136

Capitalised earnings

net result for the year (9904)
2025
€10,043
2024
-€45,089
2023
-€112,709
2022
-€55,100
Average result
-€49,252
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.